S-carboxymethylcysteine in otitis media with effusion. (A double-blind study).

S-carboxymethylcysteine syrup (SCMC); brompheniramine, phenylephrine with phenylpropanolamine elixir (BPP); and a placebo were compared in a double-blind trial in 58 children with otitis media with effusion (OME). All patients underwent myringotomies after an initial period of medical treatment. SCMC, but not BPP, was significantly better than the placebo in speeding up resolution of the effusion after surgery, as judged by pure tone audiometry, showing this drug to be a useful adjunct to the surgical management of OME. It should also be considered as an alternative to surgery.
AuthorsJ A Khan, P Marcus, S W Cummings
JournalThe Journal of laryngology and otology (J Laryngol Otol) Vol. 95 Issue 10 Pg. 995-1001 (Oct 1981) ISSN: 0022-2151 [Print] ENGLAND
PMID7028897 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Drug Combinations
  • Phenylephrine
  • Phenylpropanolamine
  • Carbocysteine
  • Brompheniramine
  • Cysteine
  • Adolescent
  • Bone Conduction (drug effects)
  • Brompheniramine (therapeutic use)
  • Carbocysteine (therapeutic use)
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Cysteine (analogs & derivatives)
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Hearing (drug effects)
  • Humans
  • Male
  • Otitis Media (drug therapy)
  • Otitis Media with Effusion (drug therapy)
  • Phenylephrine (therapeutic use)
  • Phenylpropanolamine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: